Other inhibitory glycolytic effects that contribute to cancer development, such as the glycosylation of PFK1 in response to hypoxia (59) and the Snail repression of PFK-P (60), redirect glucose flux through the PPP, thereby conferring a selective growth advantage to cancer cells. Here, PFKM is linked to cancer.